92.9 F
San Fernando
Thursday, May 26, 2022

Will Scorpion Lab Yield Venom Drugs?

Beverly Hills biotech company Medolife Rx Inc. has broken ground on a lab in the Dominican Republic to raise scorpions.Medolife Rx is a majority-owned subsidiary of Quanta Inc. in Burbank. Medolife uses peptides in scorpions to produce therapeutics. Increased quantity of the chemicals from the Dominican Republic facility will translate into mass production of its products, the company said.Currently under construction, the 2,690-square-foot facility will serve as a research lab for pipeline product Escozine, a drug to treat cancer and COVID-19.

“There has been significant ongoing research into the potential therapeutic benefits of scorpion venom for years and this facility will position us as essentially the world’s largest cultivator and researcher of these highly specific peptides,” Dr. Arthur Mikaelian, chief executive of Medolife, said in a statement.

Medolife plans to produce 1 million doses of Escozine per month with output from the Dominican Republic facility.

Featured Articles

Related Articles